Business Context and Reporting Period
This Form 8-K Current Report from Inogen, Inc. (INGN) covers events occurring on November 10, 2023, with the report filed on November 13, 2023. The filing primarily addresses a significant leadership transition at the executive level.
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation and employment terms.
- New CEO Base Salary: $700,000 annually.
- Target Annual Bonus: 100% of base salary ($700,000).
- Sign-on Bonus: $1,700,000 (paid in two installments).
- Relocation Allowance: Up to $100,000 (grossed up for taxes).
- Equity Grant: 170,000 shares total (85,000 time-based RSUs and 85,000 performance-based PSUs).
- Severance (Without Cause/Good Reason): 24 months of base salary plus COBRA benefits.
Material Changes
The primary material change is the departure of Nabil Shabshab and the appointment of Kevin Smith as President and Chief Executive Officer, effective November 10, 2023.
- Departure: Nabil Shabshab's role as an officer and employee ended effective November 10, 2023. A Separation Agreement is expected to be entered into, with terms consistent with his 2021 agreement, though specific details are pending a subsequent filing.
- Appointment: Kevin Smith was appointed CEO, President, and Class III Director (term expiring 2026).
- Background: Mr. Smith previously served as CEO of Sirtex Medical US Holdings, Inc. (2019–2023) and held executive roles at OncoSec Medical, Gel-e, Sensium Healthcare, and Teleflex.
Outlook, Risks, and Contingencies
The filing outlines specific contingencies regarding the new CEO's compensation and severance:
- Performance Goals: The 85,000 performance-based restricted stock units (PSUs) vest based on the Company's achievement of specified performance goals for 2024 and 2025.
- Clawback Provisions: If Mr. Smith is terminated for cause or resigns without good reason prior to the anniversary of incurred relocation expenses, he must repay a pro-rata portion of relocation payments and tax gross-ups.
- Change of Control: Severance benefits are enhanced if termination occurs within the "change of control period" (3 months before to 12 months after), including a lump-sum payment of the 24-month salary.
- Regulatory Compliance: The agreement includes a "full payout" or "cutback" provision to maximize after-tax benefits if payments are subject to excise taxes under Section 280G of the Internal Revenue Code.
Investor Verification Checklist
- Verify the specific performance metrics attached to the 85,000 PSUs granted to the new CEO.
- Monitor the subsequent filing for the finalized Separation Agreement terms for Nabil Shabshab.
- Review the Company's cash position to assess the immediate impact of the $1.7 million sign-on bonus and potential relocation costs.
- Confirm the vesting schedule and conditions for the 85,000 time-based RSUs.